The interactions of blood flow, A-V Or difference (AVDOJ, and A-V shunting were measured in normal hindlimbs of nine anesthetized dogs. An aorto-iliac nonpulsatile perfusion pump was used to change femoral artery blood flow from zero (collateral flow only) to twice its baseline level. Femoral AVDOr was measured by in-line spectrophotometric Or analysis. A-V shunting was measured with radio-labeled microsphercs. Systemic hemodynamic parameters and temperature remained constant during the experiments. Despite changes in femoral mean arterial pressure (160 to 54 mm Hg) and AVDOz (1.8 to 8.2 ml O/,/dl) that occurred with femoral blood tlow reduction, peripheral A-V shunting remained constant at 4.1-5.5%. Alpha-adrenergic ablation (sympathectomy) was used to increase A-V shunting (up to 20%) during part of this experiment. When hindlimb blood flow was normal or increased, autoregulation of Or extraction maintained constant hindlimb O2 consumption, despite sympathectomyinduced changes in A-V shunting. Subnormal femoral artery blood flow reduced hindhmb Oz consumption, and in this setting the increased A-V shunting further decreased femoral AVDO, and O2 consumption. Since AVDOr is dependent upon both blood flow and the variable efficiency of cellular Or extraction, it cannot be used as an accurate indicator of A-V shunting. Direct microsphere techniques should be applied to A-V shunt measurements in clinical settings where A-V shunting is suspected.
INTRODUCTION
Although peripheral arteriovenous anastomoses (AVAs) have been well documented anatomically, their physiologic function is less well defined [ 1, 191 . The potential of AVAs to divert large amounts of blood flow away from nutrient capillaries has implicated their involvement in such diverse disease states as septic shock [4, 5, lo] varicose veins [3, 111, arteriosclerosis obliterans [ 12, 2 1, 241 and portal hypertension [20] . Speculation concerning the role of AVAs in these conditions has generally been based upon measurements of peripheral arteriovenous (A-V) oxygen (02) difference (AVD02), with the assumption that a decreased AVDOz represented increased an-' Supported by the Medical Research Service of the Veterans Administration.
2 Author to whom requests for reprints should be addressed at University of Michigan Medical Center, 1405 E. Ann Street, Ann Arbor, Mich. 48109. atomic A-V shunting. Since multiple factors influence AVD02, however, extrapolation from this measurement to conclusions about peripheral A-V shunting is speculative. With radiolabeled microsphere techniques, it is now possible to directly measure A-V shunting and AVA flow [6, 151 . The purpose of this study was to specifically measure the interaction of AVD02, A-V shunting, and blood flow in perfused canine hindlimbs.
METHODS
This experiment was designed to allow local variation in canine hindlimb blood flow while maintaining stable systemic hemodynamic parameters. Mongrel dogs (22-28 kg) were anesthetized with intravenous sodium pentobarbitol(25 mg/kg), with small (5-mg) supplemental doses as necessary to maintain light anesthesia. Pentobarbitol was specifically avoided within 30 min of A-V shunt measurement to avoid changes in A-V shunting associated with acute pentobarbitol admin-&ration. Animals were intubated and ventilated with room air to maintain normal arterial blood gases. Esophageal temperature was monitored and held constant with a heating mattress and overhead heat lamp. A midline laparotomy was performed, and one external iliac artery was divided, to allow cannulation of the abdominal aorta proximally and the external iliac artery distally. Silastic tubing (3.2 mm i.d.) was then routed from the aorta through a variable-speed roller pump to the external iliac artery. All arterial branches between the aortic bifurcation and the superficial femoral artery were ligated to decrease available hindlimb collateral circulation. An appropriate-size electromagnetic flow probe (previously calibrated in vim) was placed on the superficial femoral artery. Baseline femoral artery blood flow was recorded prior to division and cannulation of the external iliac artery. Animals were systemically heparinized (200 units/kg) prior to establishing aorto-iliac pump flow.
A small muscular branch of the superficial femoral artery was cannulated to record femoral mean arterial pressure (MAP) and to administer microspheres for A-V shunt measurement (see below). Systemic MAP and heart rate (HR) were recorded via the carotid artery. Cardiac output and pulmonary artery (PA) temperature were recorded using a transjugular Swan-Ganz catheter and a thermodilution cardiac output computer. Cardiac index (CI), total peripheral resistance (TPR), and hindlimb resistance were calculated as previously described [9] .
The femoral vein was cannulated via a small muscular branch for continuous, in-line measurement of hindlimb AVD02. Venous blood from this catheter and arterial blood from a brachial artery catheter were pumped with a constant-speed tandem roller pump through an in-line spectrophotometric O2 analyzer (A-VOX Systems), which was calibrated in vivo with a Lex-02-Con oxygen analyzer (Lexington Instruments). Since total hindlimb flood flow was not measured, femoral artery flow was used to estimate hindlimb O2 consumption as: O2 consumption = femoral AVD02 ( ml/O2 min) (ml Odd0 X femoral artery flow X 0.0 1.
(ml/min) @/ml)
To calculate hindlimb O2 consumption at zero femoral artery flow, it was necessary to estimate hindlimb collateral blood flow. Based upon previous studies of femoral artery ligation, hindlimb collateral flow was estimated to represent 20% of normal femoral artery flow during the 15-min period analyzed after femoral flow cessation [ 141. Collateral flow was considered insignificant at femoral flow rates 0.5-2.0 X baseline and was not included in O2 consumption calculations for these flow rates. This estimate did not affect AVD02, which was directly measured at zero femoral artery flow.
Hindlimb A-V shunting was measured using a previously described radiolabeled microsphere technique [6-S] . Radiolabeled microspheres (25 * 10 pm diam) that pass through hindlimb AVAs after femoral artery injection become trapped in pulmonary capillaries and are measured by external thoracic scintillation detection. Comparison of this value to that obtained after a femoral venous injection (representing 100% shunting) allows multiple sequential measurements of peripheral A-V shunting.
In Part 1 of this experiment, the effect of changes in femoral blood flow upon hindlimb A-V shunting and AVD02 was determined in seven dogs using the above-described preparation. By adjusting the aorto-iliac pump, femoral artery blood flow was subsequently varied from zero to twice baseline flow in increments of 0.5X baseline flow. The above parameters were measured after they had stabilized at each flow rate, allowing 15 min for stabilization between measurements.
In Part II of this study, the effect of artificially increased A-V shunting was determined on the above variables. To increase A-V shunting from baseline levels, a lumbar sympathectomy (L2-L4) was performed through a midline incision in nine dogs. Lumbar sympathectomy has previously been demonstrated in our laboratory to significantly increase A-V shunting by alpha-adrenergic ablation [6, 8] . Simultaneous measurements of AVD02 and A-V shunting were then made at femoral artery flow rates ranging from zero to twice baseline at increments of 0.5X baseline. Since sympathectomy produces initially maximal A-V shunting, which then decreases over l-2 hr, it was possible to examine the effect of several different A-V shunt values in each animal by obtaining data points at different times during 2 hr post sympathectomy. Since the magnitude of the effect of sympathectomy on A-V shunting varies in each animal, not all dogs could be studied at each flow rate and equivalent A-V shunt value. For data analysis, shunt rates were grouped as: O-5, 5-10, and 10-20s A-V shunting and were analyzed by nonpaired statistical techniques to reflect the independence of these observations.
In Part I, each variable measured at the five different femoral artery flow rates was initially tested for statistical significance by analysis of variance. Where significant (P < 0.05) variance existed, the paired Student t test was applied to define significant differences of these variables at successive femoral artery flow rates. In Part II, analysis of variance was used to assess the effect of both femoral artery flow rate (five categories) and A-V shunting (three categories) upon AVD02 and Oz consumption. When significant variance (P < 0.05) was obtained, nonpaired Student's t test (assuming unequal variance) was used to compare these variables at successive flow rates or between different A-V shunt categories.
RESULTS

Part Z
Mean baseline femoral artery blood flow prior to aorto-iliac pump insertion was 110 ml/min. After pump insertion, alteration of femoral artery flow rate from 0 to 2.0X baseline produced no significant change in MAP, CI, TPR, HR, or PA temperature (Table 1) . Femoral artery MAP (measured distal to the aorto-iliac pump) increased from 53 to 160 mm Hg as femoral artery flow was increased from zero to twice baseline. This increase in MAP was significant at each increment of femoral blood flow (P < 0.01, Table 2 ). Correspondingly, hindlimb vascular resistance decreased significantly with each incremental increase of femoral artery blood flow (Table  2) . Changes in femoral artery flow resulted in considerable change in hindlimb AVD02 (Table 2 ). When femoral blood flow increased above baseline (1.5X, 2.0X), AVDOz decreased from 3.2 to 1.8 ml O,/dl, to yield no net change in calculated O2 consumption (3.4-3.7 ml O*/min) ( Figs. 1 and 2 ). When femoral Notes. n = seven dogs, X + SEM. Abbreviations: x, baseline femoral artery flow before perfusion pump (I 10 ml/min); C, collateral flow in hindlimb with perfusion pump OF, MAP, mean arterial pressure; CI, cardiac index; TPR, total peripheral resistance; HR, heart rate; PA temp, pulmonary artery temperature.
* No significant change at indicated flow rates. Notes. n = 7, X f SEM. Abbreviations: X, baseline femoral artery 5ow prior to perfusion pump (110 ml/min); C, collateral flow in hindlimb with perfusion pump OR, MAP, mean arterial pressure; AVDG*, arteriovenous oxygen difference.
* P < 0.05, difference between successive flow rates, paired Student's t test. ** P < 0.0 1, difference between successive flow rates, paired Student's t test.
artery blood flow decreased (0.5 and OX baseline), femoral AVD02 increased significantly (from 3.2 to 4.3 and 8.2 ml OJdl, respectively). At these low flow rates, calculated hindlimb O2 consumption also decreased, from 3.4 to 2.3 and 1.8 ml O*/min, respectively ( Table 2 , Fig. 2 ). The calculated AVD02 that would have been required to maintain constant O2 consumption despite changes in blood flow is shown by the broken line in Fig.  1 . At flow rates higher than baseline, AVDO* decreased as predicted, to maintain constant O2 consumption. At lower than baseline flow rates, however, actual increases in AVDO;, were insufficient to maintain stable O2 consumption.
Despite the above changes in femoral artery flow, femoral MAP, and hindlimb AVDO*, hindlimb A-V shunting remained constant during this study, varying insignificantly between 4.1 and 5.5% (Table 2) .
Part ZZ
Mean baseline femoral artery flow was 118 ml/min prior to aorto-iliac pump placement. As shown in Table 3 , both femoral AVD02 and hindlimb O2 consumption varied considerably with changes in femoral artery blood flow, analogous to the observation in Part I. At baseline or higher than baseline flow rates (X, 1.5X, 2.0X) increased A-V shunting had no significant effect on either AVD02 or O2 consumption (Table 3 , Fig. 3 ). At lower than baseline flow rates (0.5X, OX), however, lo-"0 collateral 0.5x Femoral AVDO* at femoral artery blood flow varying from zero (collateral flow only) to twice (2X) baseline Sow. Predicted AVDO* is that which would have been required to maintain O2 consumption equivalent to that measured at baseline (X) flow. Note significant deviation from predicted AVD02 at low 50~. 20% A-V shunting caused a significant reduction in AVDO2 and O2 consumption, compared to that seen at less than 5% shunting (P < 0.03, Fig. 3 , Table 3 ). Intermediate A-V shunting (5-10%) resulted in hindlimb AVD02 and O2 consumption that were intermediate to that seen at low (O-5%) and high (lo-20%) A-V shunting (Table 3 , Fig. 3 ).
DISCUSSION
In this experiment, hindlimb A-V shunting was varied by lumbar sympathectomy over a range that we have previously demonstrated to occur in dogs following pharmacologic alpha-adrenergic blockade [6] , after sympathectomy [8] , or during local hindlimb infection [7] . Preliminary studies by ourselves (unpublished data) and others using the same microsphere techniques in humans suggest that a O-20% range of peripheral A-V shunting is also observed clinically [ 15, 2 11. Despite these moderately large diversions of hindlimb blood flow away from nutrient capillaries, minimal and statistically insignificant changes in Or consumption were observed in this study, at normal or increased blood flow rates, presumably due to the ability of the animals to regulate (increase) O2 extraction. Only at low flow rates where significantly reduced O2 consumption was noted did increased A-V shunting further reduce peripheral O2 consumption. At such low flow rates, however, AVD02 was much more dependent upon changes in total blood flow than upon changes in anatomic A-V shunting. Thus, the ability to infer even qualitative variations in peripheral A-V shunting based upon changes in hindlimb AVDOz is poor at the shunt ranges studied in the experiment. Furthermore, any Notes. n = 9, X k SEM. Abbreviations: C, collateral flow in hindlimb with perfusion pump off; X, basline femoral artery flow before perfusion pump (I 18 ml/min); AVD@ , arteriovenous oxygen difference.
Comparison by nonpaired Student's t test: * P c 0.03, difference between successive flow rates. * P c 0.03, difference between A-V shunt ranges at same flow rate. relationship between A-V shunting and AVD02 is dependent upon assumptions of constant blood flow and metabolic rate that are often absent in clinical situations where these variables are of interest. The hindlimb perfusion system used in this experiment, combined with in-line AVDO* analysis [ 181, afforded reproducible data, with measured AVD02 being nearly identical to the AVDO* predicted to maintain constant O2 consumption at different flow rates (Fig.  1) . The effect of nonpulsatile, roller-pump perfusion upon peripheral O2 consumption, compared to pulsatile perfusion, has previously been shown to be negligible [ 13 1. Previous studies from our laboratory have shown that hindlimb perfusion per se has no significant effect on A-V shunting, including the potential influence of periarterial sympathetic nerve dissection [ 171. Baseline A-V shunt values in this study (4-6'S) agree with previous studies not employing such perfusion pumps and confirm the lack of influence of this preparation upon measured A-V shunting [6-9, 15, 211 . Peripheral A-V shunting in normothermic dogs was quite uniform in this experiment. This coincides with previous data from our laboratory using similar techniques 16-91. Core temperature, as important influence upon A-V shunting, was carefully controlled in this study. While hindlimb temperature was not measured in this experiment, previous data from our laboratory using a comparable animal preparation demonstrated insignificant changes in paw temperature, even when large increases in A-V shunting occurred [6, 71 . Predicted peripheral temperature changes of <l "C would not have been sufficient to alter hindlimb metabolism enough to cause the large changes in AVD02 observed in the current study. The observation that AVAs were not affected by large changes in flow and pressure but were affected considerably by sympathetic ablation emphasizes the role of the autonomic nervous system in the regulation of AVAs, as we have previously shown [6, 81. Results of this study concerning the differential effect of A-V shunting upon oxygen consumption at different flow rates may help explain different clinical results following lumbar sympathectomy [2] , a procedure known to increase AVA flow rather than nutrient capillary flow [8, 211. Several investigators have suggested that only patients with moderately good peripheral blood flow respond favorably to lumbar sympathectomy. In this regard, a positive clinical response has been predicted by an ankle-brachial index greater than 0.35 [23], a distal-thigh index greater than 0.7 [ 161, or an absolute ankle pressure greater than 30 mm Hg 1221. Despite the effect of sympathectomy to increase nonnutritive AVA flow, a potential benefit of this procedure may be the stimulation of increased collateral blood flow due to the pressure gradient created by distal vasodilatation. Although such improved collateral blood flow may not persist beyond the 6-8 week hyperemit period following sympathectomy, this is a common explanation for beneficial effects of this procedure. Results of the current study would support the concept that patients with only moderately reduced peripheral blood flow could respond favorably to sympathectomy. This would be due to their ability to increase cellular oxygen extraction sufficiently to overcome increased AVA flow seen during the acute hyperemic period, perhaps resulting in a net gain in oxygen delivery. Patients with very low blood flow, however, probably have cellular oxygen extraction that is already maximal and is unable to compensate for increased AVA flow associated with sympathectomy. This would result in a net decrease in total 02 consumption, despite increased collateral blood flow, analogous to the results noted during low femoral blood flow and high A-V shunting in our current animal experiment. Although this hypothesis requires direct clinical testing, it may help explain the variable response of patients to sympathectomy, as related to the level of preexisting extremity blood flow, defined by the noninvasive laboratory studies referred to above. Results of this study strongly suggest that previous investigations using indirect AVDOp measurement to assess the role of peripheral A-V shunting should be reexamined. The microsphere technique for A-V shunt measurement described in this report is applicable to human use. Direct shunt measurement in clinical disorders where A-V shunting has been implicated is required to accurately quantitate the patho-physiologic role of AVAs in human disease.
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